Aminoff MJ: Treatment of Parkinson's disease. West J Med 161:303, 1994

Bennett DA et al: Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334:771, 1996

Cleeter MWJ et al: Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement. J Neurochem 58:786, 1992

Dogali M et al: Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 45:753, 1995

Edwards RH: Neural degeneration and the transport of neurotransmitters. Ann Neurol 34:638, 1993

Gratz SS, Simpson GM: Neuroleptic malignant syndrome. Diagnosis, epidemiology and treatment. CNS Drugs 2:429, 1994

Hyde TM, Weinberger DR: Tourette's syndrome: A model neuropsychiatric disorder. JAMA 273:498, 1995

Iannaccone S et al: Evidence of peripheral axonal neuropathy in primary restless legs syndrome. MovDisord 10:2, 1995

Kordower JH et al: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesen-cephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118, 1995

Lozano AM et al: Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 346:1383, 1995

Mouradian MM et al: Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Ann Neurol 27:18, 1990

Nygaard TG et al: Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nature Genet 5:386, 1993

Parkinson Study Group: Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 328:176, 1993

Parkinson Study Group: Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Ann Neurol 39:29, 1996

Polymeropoulos MH et al: Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274:1197, 1996

Quinn N: Drug treatment of Parkinson's disease. BMJ 310:575, 1995

Remy P et al: Clinical correlates of [l8F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 38:580, 1995

Schulzer M et al: The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic. Ann Neurol 32:795, 1992

Wichmann T et al: Parkinson's disease and the basal ganglia: Lessons from the laboratory and from neurosurgery. Neuroscientist 1:236, 1995